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Available online 18 April 2016Background: Due to the widespread resistance of Plasmodium falciparum to chloroquine drug, artemisinin-based
combination therapy (ACT) has been recommended as the ﬁrst-line treatment. This study aims to evaluate the
extent of chloroquine resistance in P. falciparum infection after the introduction of ACT. This study was carried
out based on the mutation analysis in P. falciparum chloroquine resistant transporter (pfcrt) and P. falciparum
multidrug resistance 1 (pfmdr1) genes. Identiﬁcation of these molecular markers plays a signiﬁcant role in mon-
itoring and assessment of drug resistance as well as in designing an effective antimalarial drug policy in India.
Methods: Sixty blood samples were collected from patients infected with P. falciparum from JIPMER, Puducherry
and MKCG Medical College, Odisha. Polymerase chain reaction-restriction fragment length polymorphism was
performed, targeting the point mutation of K76T in pfcrt and N86Y in pfmdr1 gene. The PCR products were se-
quenced, genotyped and further analysed for amino acid changes in these codons.
Results: The frequency of pfcrtmutation at 76th position was dominant for mutant T allele with 56.7% and wild
type K, 43.3%. Majority of pfmdr1 86 allele were wild type, with N (90%) and mutant, Y (10%). Additionally, we
found three haplotypes for CQ resistance, SVMNT, CVIET and CVIKT in association with the pfcrt gene. However,
a poorly studied SNP in pfmdr1 gene (Y184F) associated with CQ resistance showed high frequency (70%) in
P. falciparum isolates.
Conclusions: The point mutation K76T of pfcrt is high in P. falciparum suggesting a sustained high CQ resistance
even after ﬁve years of the introduction of ACTs for antimalarial therapy. The present study suggests a strong as-
sociation of CQ resistance with pfcrt T76, but not with the pfmdr1 Y86 mutation. However, sequence analysis
showed that Y184F mutation on pfmdr1 gene was found to be associated with high resistance. Also, a new
pfcrt haplotype ‘CVIKT’ associated with CQ resistance was found to be present in Indian strains of P. falciparum.
The data obtained from this study helps in continuousmonitoring of drug resistance inmalaria and also suggests
the need for careful usage of CQ in Plasmodium vivaxmalarial treatment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Malaria is a serious public health burden occurring mainly in the
tropical and subtropical regions of theworld.WHOestimated 1.2 billionciparum chloroquine resistance
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. This is an open access article underpeople are at high risk of malaria infection globally [1]. It is a vector-
borne infectious disease, caused by Apicomplexan parasite belonging
to Plasmodium genus, which is transmitted to humans through an in-
fected Anopheles mosquito during the blood meal. Of the ﬁve human-
infecting malaria parasites, Plasmodium falciparum is the most virulent
and deadliest parasite and responsible for high mortality andmorbidity
rate. The emanation of drug resistance in P. falciparum is a major threat
to the malaria control and eradication program running across the
globe. The ﬁrst chloroquine (CQ) resistance in P. falciparum was re-
ported in Southeast Asia along the Thai-Cambodian border during the
late 1950s [2,3]. In India, 50% of the malaria infections are due to
P. falciparum and predominately in the forest, and hilly areas [4]. The
ﬁrst report of CQ resistance was recorded from Karbi-Anglong district,
Assam in 1973 [5].the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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inhibiting the heme detoxiﬁcation pathway [6,7]. CQ resistance occurs
due to the reduced accumulation of the drug in the digestive vacuole
of the parasite. There are twomolecularmarkers available for determin-
ing the CQ resistance: P. falciparum chloroquine resistance transporter
(pfcrt) and P. falciparum multidrug resistance (pfmdr1). The pfcrt gene
localised on chromosome 7 has 13 exons and ten putative transmem-
brane domains spanning the digestive vacuole of the parasite [8,9].
pfmdr1 gene located on chromosome 5 encodes for P-glycoprotein ho-
mologue 1 (Pgh1) protein present in the digestive vacuole of the para-
site [10,11]. Mutation in the PfCRT protein at K76T is the primary
determinant for CQ resistance [8,12], whereas N86Y mutation in
PfMDR1 protein may enhance the degree of resistance [11]. Mutation
in other regions of these PfCRT and PfMDR1 protein also confers resis-
tance to CQ, but exclusively in the presence of K76T mutation.
The present studywas aimed to ascertain the prevalence of pfcrt K76T
and pfmdr1 N86Y mutation in two communities (high and low malaria
endemic regions) of India. Thus, continuous monitoring and assessment
of themolecularmarker of drug resistance play a signiﬁcant role in deter-
mining whether resistance has faded after the cessation of drug usage.
Also, it helps to map the evolutionary analysis of pfcrt haplotypes and to
identify new mutations in the pfcrt and pfmdr1 gene. In the current
study, clinical isolates from two communities were collected and CQ
molecular marker, pfcrt and pfmdr1, were studied and analysed to under-
stand the degree of CQ resistance and mapping of pfcrt haplotypes.
2. Results
2.1. RFLP analysis
A total of 60 positive samples of P. falciparum were collected from
JIPMER, Puducherry (n = 30) and MKCG Medical College, Odisha
(n = 30) with unknown CQ sensitivity. DNA from these isolates were
analysed for CQ resistance based on the presence of K76T andN86Ymu-
tation in pfcrt and pfmdr1 gene respectively. Restriction digestion of the
pfcrt product with ApoI enzyme produced two fragments (128 &
136 bp) in 26 isolates showing the presence of K76 codon, which indi-
cates sensitivity to CQ. The remaining 34 isolates were resistant to di-
gestion conferring the presence of mutant T76 codon and CQ drug
resistance (Table 1). The pfmdr1 gene product of six samples gets
digested into two fragments (253 & 350 bp) with AﬂIII enzyme, indicat-
ing the presence of mutant Y86 codon conferring CQ resistance. Rest of
the isolates (n= 54) were CQ-sensitive indicating the presence of wild
type N86 codon (Table 1). There was no signiﬁcant association between
the pfcrt K76T and pfmdr1 N86Y mutation in our study population.
2.2. Sequence analysis
The pfcrt and pfmdr1 PCR amplicons were sequenced to conﬁrm the
presence of K76T and N86Ymutations. Additionally, the sequencing re-
sults were used to ﬁnd out the new mutations in pfcrt and pfmdr1 re-
gions. The pfcrt and pfmdr1 gene product were sequenced for a total of
30 P. falciparum samples (n = 15 from each centre, randomly) in both
forward and reverse direction. Further, these sequences were alignedTable 1
Detection of CQ resistance in Puducherry andOdisha P. falciparum isolates using RFLP anal-
ysis. CQ-resistance was mainly attributed to K76T and N86Y mutation in the pfcrt and
pfmdr1 gene respectively. CQ-resistant parasites were higher in Odisha whereas almost
equal in Puducherry regions even after the withdrawal of CQ.
No of samples
(n)
pfcrt-K76T pfmdr1-N86Y
Sensitive Resistant Sensitive Resistant
Puducherry 30 18 (60%) 12 (40%) 26 (86.67%) 4 (13.33%)
Odisha 30 8 (26.67%) 22 (73.33%) 28 (93.33%) 2 (6.67%)
Total 60 26 (43.33%) 34 (56.67%) 54 (90%) 6 (10%)by using Clustal Omega tool, which identiﬁed six SNPs in the pfcrt
gene and three SNPs in the pfmdr1 gene. The DNA sequence reads of
both genes were translated into amino acid codon using Expasy trans-
late tool. Six pointmutationswere observed in the PfCRT amino acid se-
quence at 72nd, 74th, 75th, 76th and 97th position and two point
mutations were recorded in PfMDR1 amino acid sequence at 86th and
184th codon position (Fig. 1). All these eight SNPs detected in both
the genes were nonsynonymous substitution. One synonymous muta-
tion in the pfmdr1 gene, GGT to GGG coding for glycine amino acid res-
idue at the 182nd position, was found in 20 isolates.
Overall, four haplotypes of the pfcrt gene (CVMNK, SVMNT, CVIET
and CVIKT) were found in P. falciparum isolates collected from
Puducherry, whereas three haplotypes (CVMNK, SVMNT and CVIET)
were observed in Odisha samples. Among Puducherry isolates, SVMNT
haplotype was found most frequently (n = 10), followed by CVMNK
(n = 3), CVIET (n = 1) and CVIKT (n = 1) haplotypes. In Odisha iso-
lates, CVIET haplotype was observed most frequently (n = 10),
followed by SVMNT (n = 4) and CVMNK (n = 1) haplotypes. In most
of pfmdr1 gene, N86 allele was the wild type with 80%, and F184 allele
was mutant with 73.33%. The pfmdr1 gene of the Puducherry isolates
frequently showed N86F184 codons (66.67%), followed by Y86Y184
(26.67%) and thewild type condon, N86Y184 (6.67%). Similarly, inOdisha
isolates, N86F184 codons were more prevalent (73.33%), followed by
Y86Y184 (13.33%) and wild type, N86Y184 (13.33%). Combining the
mutational analysis of pfcrt and pfmdr1 genes in both populations
revealed the presence of 11 distinct haplotypes among the 30
Southeast Indian P. falciparum isolates tested in the present study
(Table 2). Among the 11 haplotypes identiﬁed, H1 haplotype
(S72V73M74N75T76H97N86G182F184) was most commonly distributed
with 43.33% frequency. The H1 haplotype was more prevalent (n = 9)
in Puducherry P. falciparum isolates and less frequent (n= 4) in Odisha
population. The combined results of pfcrt and pfmdr1mutational analy-
sis reveal the highest haplotype diversity among the P. falciparum iso-
lates obtained from Odisha.
2.3. Assessment of genetic diversity
DNA sequence analysis of the 264 bp of pfcrt coding sequence show
highest haplotype diversity in Odisha (Hd, 0.743) and lowest in
Puducherry (Hd, 0.543) (Table 3). Also, θw and π estimates of Odisha
P. falciparum isolates have the highest nucleotide diversity when com-
pared to Puducherry isolates. Similarly, the 603 bp pfmdr1 sequence
analysis show slightly high haplotype diversity in Puducherry (Hd,
0.6) than Odisha (Hd, 0.562). The θw and π estimates of the nucleotide
diversity show highest values in Puducherry samples than Odisha
(Table 3). Also, π values are slightly higher than the θw values in both
genes, suggesting a larger number of intermediate frequencymutations
in both the population. The neutrality tests show no statistically signif-
icant results for all the three tests conducted to indicate any divergenceFig. 1. Distribution of pfcrt and pfmdr1 alleles P. falciparum isolates collected from
Puducherry and Odisha, India. K76T mutation in the pfcrt gene showed higher frequency
associated with CQ-resistance. However, in the pfmdr1 gene, the Y184Fmutation showed
a higher distribution of frequency.
Table 2
Details of haplotypes present fromPuducherry andOdisha region isolates, India. The num-
ber of haplotypes were obtained by combining the mutation present in both the pfcrt and
pfmdr1 gene of Southeast Indian P. falciparum isolates. H1 haplotype showed high fre-
quency present mainly in Puducherry region.
Haplotype
ID
Haplotype No of
isolates
(n)
Frequency of
haplotypes
(%)
H1 S72V73M74N75T76H97N86G182F184 13 43.33
H2 S72V73M74N75T76H97Y86G182Y184 1 3.33
H3 C72V73I74E75T76H97N86G182F184 3 10.00
H4 C72V73I74E75T76L97N86G182F184 4 13.33
H5 C72V73I74E75T76H97N86G182Y184 1 3.33
H6 C72V73I74E75T76H97Y86G182Y184 2 6.67
H7 C72V73I74E75T76L97Y86G182Y184 1 3.33
H8 C72V73I74K75T76H97Y86G182Y184 1 3.33
H9 C72V73M74N75K76H97N86G182Y184 2 6.67
H10 C72V73M74N75K76H97N86G182F184 1 3.33
H11 C72V73M74N75K76H97Y86G182Y184 1 3.33
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signiﬁes that both population P. falciparum isolates are evolving under
the neutral model of molecular evolution and no involvement of selec-
tion pressure in both the pfcrt and pfmdr1 genes.
To determine the role of natural selection in the pfmdr1 gene, the dN
and dS values were estimated for each population independently, and
Z-test was performed for codon-based natural selection test (Table 3).
The P value of the Z-test for natural selection was signiﬁcantly higher
than the 5% level of signiﬁcance (data not shown), suggesting no role
of evolutionary natural selection in the pfmdr1 gene in samples of
both population and it conﬁrms with Tajima's D test of neutrality ﬁnd-
ings. Furthermore, LD was determined by estimating r2 values between
all possible pairs of SNPs present in both pfcrt and pfmdr1 genes to study
their genetic association (Fig. 2). Statistically signiﬁcant intragenic asso-
ciations were detected between SNP pairs in the pfcrt gene, but no
intergenic association found between the pfcrt and pfmdr1 genes.3. Discussion
The advancement in the molecular techniques is extremely useful
for the detection of drug resistance in malarial parasites and plays an
immense role in the epidemiological survey as well as in regular
updating of the antimalarial drug policy regimes. The CQ resistance in
P. falciparum has been associated with pfcrt and pfmdr1 genes [13,14].
However, the mutation in the pfcrt gene at K76T position has beenTable 3
Details of genetic diversity of pfcrt and pfmdr1 genes in P. falciparum isolates collected from
Puducherry and Odisha. The genetic parameters and tests of neutrality were calculated
using DnaSP program. The high haplotype and nucleotide diversity were observed in the
pfcrt sequence analysis fromOdisha isolates,which is due to the highmalaria transmission
rate. However, the Puducherry isolates showed high haplotype and nucleotide diversity in
the pfmdr1 analysis.
Gene pfcrt pfmdr1
Population Puducherry Odisha Puducherry Odisha
No of isolates (n) 15 15 15 15
SNPs (n) 6 6 3 3
No of haplotypes (n) 4 3 4 5
Haplotype diversity (Hd) 0.543 0.743 0.6 0.562
Nucleotide diversity θ 0.00699 0.00699 0.00153 0.00153
π 0.00599 0.00909 0.00234 0.0018
Tests of neutrality
Tajima's D −0.50145 1.05243 1.56977 0.52578
Fu and Li′s D* −0.01484 0.63222 1.05657 1.05657
Fu and Li′s F* −0.16644 0.85232 1.35864 1.04652
Tajima's D (NonSyn/Syn)
ratio
na na 0.871 0.29732considered as the primary determinant for CQ resistance [8,12]. On
the other hand, pfmdr1 gene mutation has poor correlation with CQ re-
sistance [11,15]. Thus, tracking mutation in these candidate genes and
ﬁnding new mutations and its association, could help us in the better
understanding of how the genetic change in genes could alter the phe-
notypic characters, and also how genetic recombination evolve in re-
sponse to drugs used for therapy [16].
This is a hospital-based prevalence study performed to monitor the
CQ resistance based on the detection of the point mutation in the pfcrt
and pfmdr1 genes by PCR-RFLP method. In the present study, the prev-
alence of pfcrt K76T mutation was 40% and 73.33% in Puducherry and
Odisha population respectively. Similarly, the N86Y mutation in the
pfmdr1 gene was found to be 13.33% and 6.67% by PCR-RFLP in
Puducherry and Odisha population respectively. In some studies, the
N86Y mutation was associated with CQ resistance [17–19], whereas,
in other studies this association was not found [20–24]. In the present
study population, there was no association of N86Y mutation of the
pfmdr1 gene with CQ resistance and this non-association was in agree-
ment with previous ﬁndings [16,20,25,26]. However, the prevalence of
N86Y mutation was high in other Indian P. falciparum isolates [16,27,
28].
The frequency of CVIET haplotype of the pfcrt gene was dominant in
Odisha P. falciparum isolates and correlates with earlier reports from
Odisha [16,27]. Furthermore, the SVMNT haplotype of the pfcrt gene
was seen with high frequency in Puducherry. The use of Amodiaquine
(AQ) drug, reported to select the SVMNT haplotype in P. falciparum iso-
lates [29,30], but in Puducherry, in spite of no usage of AQ, this haplo-
type was found to be highly frequent. The prevalence of SVMNT
haplotype of the pfcrt gene in Indian P. falciparum isolates could be
due to the ongoing migration of SVMNT from Papua New Guinea to
Southeast Asia and India [31,32]. Thus, either the usage of AQ as single
or in combination therapy should be avoided in future for malaria treat-
ment in Puducherry.
Interestingly, a new haplotype CVIKT (triple mutant) of the pfcrt gene
has been observed in Puducherry. This haplotype was ﬁrst reported from
Indonesia, Papua New Guinea (Indonesian Papua) with less frequency
[33]. Hence, this will represent the ﬁrst report of the CVIKT haplotype
from Indian population, and it could be due to the migration from
Papua New Guinea, like similar kind of migration observed in the case
of SVMNT haplotype. Furthermore, a nonsynonymous mutation H97L in
the pfcrt gene was observed with appreciable frequency in P. falciparum
isolates obtained from Odisha than in Puducherry. Previously, the H97L
mutation in pfcrt gene has been reported in CQ resistance isolates of
P. falciparum [8,34,35], including the report from Odisha [27].
When the N86Y mutation of the pfmdr1 present along with K76T
mutation of the pfcrt gene has been argued to associate with the CQ re-
sistance in P. falciparum isolates [13,36]. Additionally, in India, statisti-
cally signiﬁcant LD between these two mutations have been reported
[27]. In the present study, no signiﬁcant LD between the K76Tmutation
in the pfcrt and N86Y mutation in the pfmdr1 gene was observed. How-
ever, the mutation in the 72nd, 74th and 75th position of the pfcrt gene
showed signiﬁcant LD association. Further, the results of non-
association of K76T and N86Y mutation correlates with previous ﬁnd-
ings from India [16]. Although these mutations have no direct role in
CQ resistance, studies have shown high LD association of 72nd, 74th
and 75th mutation in the pfcrt gene [16,27].
Similarly, Y184F mutation in the pfmdr1 gene was associated with
CQ resistance [13], and studies have shown its negative correlation to
CQ resistance [19]. However, a previous study fromOdisha has reported
the high prevalence of N86Ymutation and lowprevalence of Y184Fmu-
tation [27]. The Y184F mutation is associated with Artemisinin
Lumefantrine (AL) resistance and N86F184 genotype in eastern Sudan
have shown the increase in treatment failure to AL in P. falciparum iso-
lates [37,38]. However, in India, P. falciparum isolateswithN86F184 geno-
type were sensitive to AL therapy [39]. Further, the presence of
synonymous mutation, G182G, in the pfdmr1 gene was a remarkable
Fig. 2. Linkage disequilibrium plot between the SNPs pairs of pfcrt and pfmdr1 gene in Indian P. falciparum. The intergenic and intragenic association between the genes were illustrated
using the LD plot for isolates collected from (a) Puducherry and (b) Odisha regions. The strength of LD between the SNPs is determined by the association of statistical signiﬁcance by
calculating the r2 values and represented by the darkness of the boxes.
88 H.A. Antony et al. / Genomics Data 8 (2016) 85–90ﬁnding, since this mutation was present in other Indian ﬁeld isolates
and cultured isolates indicating the presence of this mutation since a
long time in India [16]. Though this mutation does not change the
amino acid, itmight involve in altering transport kinetics since it is pres-
ent near to the 184 amino acid residue [40].
In Odisha, the high number of haplotypes combining the pfcrt and
pfmdr1 genes was due to the high malaria transmission rate, resulting
in high haplotype diversity. Similar ﬁndings of high haplotype diversity
has been observed in pfcrt-pfmdr1 genes in Odisha [16], along with mi-
crosatellite variation in and around the pfcrt gene [41]. Thus, whole se-
quence analysis of pfcrt and pfmdr1 gene with larger sample size
covering wider population is needed to understand clearly the molecu-
lar evolution pattern in both pfcrt and pfmdr1 of P. falciparum isolates in
India.
In the present study, theπ values of nucleotide diversitywere higher
for pfmdr1 gene and lower for the pfcrt gene in Puducherry isolates than
Odisha. The ﬁnding of high nucleotide diversity for the pfmdr1 gene in
Puducherry (low endemic region) than Odisha (high endemic region)
is interesting, and contrast to the general perspective of P. falciparum
[42]. Similar ﬁndings of high nucleotide diversity were reported in an-
other Indian state, Gujarat (low endemic region), in comparison to
high malaria endemic regions of Odisha and Assam [16,43]. The haplo-
type and nucleotide diversity of pfmdr1 genewere higher in Puducherry
population than Odisha, which could be due to the comparatively larger
number of haplotypes. Furthermore, linkage disequilibrium between
N86Y and Y184F mutation in Odisha isolates show statistically weaker
association than the Puducherry isolates. Though Puducherry is consid-
ered as less endemic to P. falciparum malaria, genetic diversity was
higher with less LD signiﬁcance than Odisha isolates with less genetic
diversity and weaker LD association. Large-scale genetic population
studies are required to compare the LD association of low and high en-
demic regions of P. falciparum samples.
P. vivaxmalarial infection is prevalent inmany parts of theworld [1].
Chloroquine is the treatment of drug choice for P. vivax infection which
kills the asexual stages of the parasite in the blood, along with
primaquine that kills the hypnozoite stages of the parasite in the liver.
In Papua New Guinea and Indonesia, resistance to chloroquine treat-
ment in P. vivax infection was ﬁrst emerged in the late 1980s [44].
Since then chloroquine resistance has been documented in many re-
gions of the world [45,46]. WHO recommends the use of ACT in areas
where chloroquine resistance has been reported for P. vivax infection
[1]. Hence, chloroquine should be used carefully for P. vivax treatment
to prevent/delay the drug resistance. Several drug resistant molecular
markers have been identiﬁed for the detection of drug resistance in
P. vivax [47–49]. These markers provide valuable information in
P. vivax treatment since in vitro culturing of P. vivax is difﬁcult. Thus,
drug resistantmolecularmarker helps in the early detection and contin-
uous monitoring of drug resistance, which aid in effective drug policy
regimes.4. Conclusion
The survey of pfcrt and pfmdr1 gene fragments associated with CQ
resistance study in high and lowmalaria endemic areas of India beneﬁt
us in understanding themolecular evolutionary changes in P. falciparum
isolates. This study has limitations due to the fewer P. falciparum isolates
from Puducherry region due to their low endemicity and less number of
DNA sequencing results in both regions. Despite its drawbacks, the re-
sults obtained from this study has its signiﬁcance in unravelling the ge-
netic diversity pattern and genetic associations between the mutations
in pfcrt and pfmdr1 genes of P. falciparum collected from low and high
endemic regions of India. Thus, large-scale molecular epidemiological
studies on antimalarial drug resistance markers are needed to identify
the previously existing and new mutation in the particular genes that
contribute to the drug resistance in malaria. All this molecular epidemi-
ological data are in turn helpful in regular revisal of antimalarial drug
policies.
5. Materials and methods
5.1. Ethical clearance
This studywas reviewed and approved by JIPMER Scientiﬁc Advisory
Committee and Institute Ethics Committee for sample collection in
JIPMER, Puducherry. Similarly, Institutional Ethics Committee approval
was also obtained for sample collection in MKCG Medical College,
Odisha.
5.2. Sample collection & DNA extraction
Totally sixty P. falciparum positive blood samples collected from two
tertiary care hospitals, JIPMER, Puducherry (low endemic region) and
MKCG Medical College, Odisha (high endemic region), constitute the
samples for this study. Routine blood samples received for malaria in-
vestigation in Parasitology Section were screened by examination of
thin and thick smears using Giemsa staining and rapid diagnostic test
(RDT). The samples positive for P. falciparum by microscopy and RDT
were included in the study. Artemisinin combination therapy was pro-
vided for treatment of malaria in both the centres based on National
Drug Policy of India [4].
P. falciparum genomic DNAwas extracted from 200 μl of EDTA-blood
using Qiagen Blood DNA Mini kit (Qiagen, Hilden, Germany) following
manufacture's protocol, and stored at−20 °C until further use.
5.3. PCR for pfcrt and pfmdr1
The K76T and N86Y mutation in the pfcrt and pfmdr1 gene respec-
tively, which are the primary determinants ofmarkers for CQ resistance,
were targeted using PCR (Agilent SureCycler 8800, CA, USA). A 264 bp
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which contain K76T mutation was ampliﬁed using the primer pair 5′-
GGCTCACGTTTAGGTGGA-3′ and 5′-TGAATTTCCCTTTTTATTTCCAAA-3′,
as described earlier [50]. Similarly, the pfmdr1 gene containing the
N86Y mutation in the extreme 5′ end of the gene was ampliﬁed by
the primer set 5′-ATGGGTAAAGAGCAGAAAGA-3′ and 5′-AACGCAAG
TAATACATAAAGTCA-3′ to obtain a 603 bp gene fragment, correspond-
ing to 1 to 201 amino acid residues [50].
5.4. Restriction digestion with ApoI and AﬂIII
The ﬁnal PCR ampliﬁed product of pfcrt and pfmdr1 gene was enzy-
matically digested with ApoI and AﬂIII (New England Biolabs, UK) re-
spectively. Digestion of the pfcrt PCR product into two fragments (128
& 136 bp) with ApoI enzyme confers that the isolate was sensitive to
CQ with CVMNK haplotype, whereas, the K76 T mutation was resistant
to digestion [50]. On the other hand, when the pfmdr1 gene productwas
digested with AﬂIII enzyme, it cleaved into two fragments, i.e., 253 and
350 bp, and these isolates were considered as CQ-resistant with mutant
Y allele at 86th position. However, CQ-sensitive isolates were resistant
to restriction digestion [50]. Further, the digested fragments were re-
solved by electrophoresis on 1.8% agarose gel stained with ethidium
bromide and visualised using gel documentation system (Biorad, USA).
5.5. Genotyping of pfcrt and pfmdr1
The undigested PCR products of pfcrt and pfmdr1 genes were chosen
randomly (15 from each centre) for sequencing to determine the haplo-
types of CQ resistance in pfcrt gene, based on themutation in 72–76 co-
dons and to ﬁndnovel single nucleotide polymorphisms (SNPs) in these
genes. The PCR products were gel puriﬁed with FavorPrep PCR/Gel pu-
riﬁcation kit (Favorgen, Taiwan) using manufacture's protocol. Se-
quencing was performed using ABI 3730XL automated DNA sequencer
in both forward and reverse directions (2× coverage) at Scigenom
Labs, Cochin, India. DNA sequence reads were aligned using BioEdit
7.2 software [51] and analysed using Clustal Omega tool [52]. Haplo-
types of these isolates were determined based on SNPs present in
these gene fragments by comparing the multiple sequence alignments
with reference to the CQ-sensitive P. falciparum 3D7 strain. The se-
quence reads were deposited in GenBank with accession no.
KU376443-KU376472 and KU493989-KU494018.
5.6. Statistical analysis
Data analysis for RFLP studywas performed by using SPSS version 16
(SPSS Inc., Chicago IL) [53]. The statistical association between the point
mutations and the independent variable were analysed using Chi-
square test and a p-value ≤ 0.05 was considered statistically signiﬁcant.
The aligned pfcrt and pfmdr1 coding sequences were used to determine
the number of haplotypes and haplotype diversity (Hd) [54]. Also, two
measures of nucleotide diversities, θw and π [55,56], were estimated
separately for each sample population. These parameters were calcu-
lated by using the computer program DnaSP version 5.10 [57]. Further-
more, the frequency of non-synonymous substitutions per non-
synonymous site (dN) and the frequency of synonymous substitutions
per synonymous site (dS) were determined for the two population,
and a Z-test was performed to calculate the p-value using the MEGA,
version 6 program [58]. To resolve whether there is any association be-
tween nine SNPs in two population (present in both pfcrt and pfmdr1
genes), both inter and intragenic linkage disequilibrium (LD) were de-
termined by calculating the r2 values for each possible pair-wise SNP,
using the program Haploview [59].
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